Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database

Br J Dermatol. 2016 Nov;175(5):1067-1069. doi: 10.1111/bjd.14649. Epub 2016 Aug 11.

M S Agier¹, N Boivin¹, A Maruani^{2

3

4}, B Giraudeau^{3

5}, A Gouraud⁶, F Haramburu⁷, M J Jean Pastor⁸, L Machet^{2

3

4}, A P Jonville-Bera⁹

¹ Department of Clinical Pharmacology, Regional Pharmacovigilance Center, CHRU Tours, 37044, Tours CEDEX 9, France.
² Department of Dermatology, CHRU Tours, 37044, Tours CEDEX 9, France.
³ University François Rabelais Tours, 37000, Tours, France.
⁴ INSERM U930, 37044, Tours CEDEX 9, France.
⁵ Clinical Investigation Center - INSERM 1415, 37044, Tours CEDEX 9, France.
⁶ Regional Pharmacovigilance Center, Hospices Civils de Lyon, 69424, Lyon, France.
⁷ Department of Clinical Pharmacology, Regional Pharmacovigilance Center, Hôpital Pellegrin, 33076, Bordeaux, France.
⁸ Regional Pharmacovigilance Center, Hôpital Salvator, Assistance Publique Hôpitaux de Marseille, 13274, Marseille, France.
⁹ Department of Clinical Pharmacology, Regional Pharmacovigilance Center, CHRU Tours, 37044, Tours CEDEX 9, France. jonville-bera@chu-tours.fr.

No abstract available

Publication types